Search for: "Warner-Lambert Company, LLC." Results 81 - 97 of 97
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Mar 2018, 7:36 am by Matrix Legal Support Service
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor was heard on the 12-15 Feb 2018. [read post]
16 Apr 2018, 1:00 am by Matrix Legal Support Service
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor, heard 12-15 Feb 2018. [read post]
26 Feb 2018, 1:00 am by Matrix Legal Support Service
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor, heard 12-15 Feb 2018. [read post]
25 Jan 2009, 2:36 pm
McKinnell, while being groomed as CEO in 2001, was instrumental in Pfizer's $115 billion acquisition of Warner- Lambert Co., the developer of Lipitor. [read post]
30 Apr 2018, 1:00 am by Matrix Legal Support Service
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor, heard 12-15 Feb 2018. [read post]
14 May 2018, 1:00 am by Matrix Legal Support Service
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor, heard 12-15 Feb 2018. [read post]
4 Jun 2018, 1:00 am by Matrix Legal Support Service
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor, heard 12-15 Feb 2018. [read post]
11 Jun 2018, 1:00 am by Matrix Legal Support Service
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor, heard 12-15 Feb 2018. [read post]
17 Jun 2012, 3:52 pm by Stephen Jenei
Research and Development communications and re-branding strategies for the company’s Warner-Lambert merger and Pharmacia acquisition. [read post]
The most famous decision might be the UK Supreme Court’s Ruling in Warner-Lambert Company LLC v Generics (UK) Ltd, which was reported on this blog here. [read post]
29 Oct 2018, 2:00 am by Matrix Legal Support Service
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor, heard 12-15 Feb 2018. [read post]
15 May 2009, 1:03 am
Pfizer Again Beats Back Class Certification Motion in Consumer Fraud Case The American Lawyer Shortly after Pfizer predecessor Warner-Lambert agreed to pay more than $430 million to resolve criminal charges and civil liabilities for promoting off-label uses for its epilepsy drug Neurontin in 2004, plaintiffs lawyers sought to represent a nationwide class of consumers and third-party payers against the pharmaceutical giant, demanding more than $4 billion… [read post]
12 Feb 2008, 8:29 am
Kent case shows how reluctant courts can be to admit that §337(a) means what it says (in Farm Raised Salmon, the pending Warner-Lambert v. [read post]
6 Mar 2014, 12:41 pm
  But, recognizing the primacy of federal law in this field, the Illinois statute itself protects companies from liability if their actions are authorized by federal law.Id. at 941. [read post]
11 Jul 2008, 4:30 am
: (Spicy IP), India: Ranbaxy-Daiichi deal – Opportunities for private equity companies in India: (Profitability through Simplicity), India: (KEI) Cracking open anti-competitive practices in the developing world: complaints, amendments and waivers: (Spicy IP), India: Is it one rule for Indian pharma companies and another one for those from abroad? [read post]
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay generics in 2007:… [read post]
28 Jun 2017, 9:26 am by Barry Sookman
Norwich supplies a principled rationale for granting injunctions against non-parties who facilitate wrongdoing (see Cartier, at paras. 51-55; and Warner-Lambert Co. v. [read post]